Glycogen synthase kinase 3β inhibition enhances Notch1 recycling

被引:21
|
作者
Zheng, Li [1 ]
Conner, Sean D. [1 ]
机构
[1] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA
基金
美国国家卫生研究院;
关键词
MUTATIONS; DYNAMICS; INSIGHTS; GROWTH;
D O I
10.1091/mbc.E17-07-0474
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The Notch signaling pathway is essential throughout development and remains active into adulthood, where it performs a critical role in tissue homeostasis. The fact that defects in signaling can lead to malignancy illustrates the need to control Notch activity tightly. GSK3 beta is an established regulator of the Notch signaling pathway, although its mechanism of action remains unclear. Given the emerging role for GSK3 beta in receptor trafficking, we tested the idea that GSK3 beta controls signaling by regulating Notch transport. Consistent with published reports, we find that GSK3 beta inhibition enhances Notch1 signaling activity. Immunolocalization analysis reveals that Notch1 localization within a tubulovesicular compartment is altered when GSK3 beta activity is disrupted. We also find that receptor cell surface levels increase following acute GSK3 beta inhibition. This is followed by elevated Notch intra-cellular domain (NICD) production and a corresponding increase in signaling activity. Moreover, Notch transport assays reveal that receptor recycling rates increase when GSK3 beta activity is inhibited. Collectively, results presented here support a model where GSK3 beta regulates signaling by controlling postendocytic transport of Notch1. Given that GSK3 beta activity is suppressed following stimulation by multiple signal transduction pathways, our findings also suggest that cells can modulate Notch1 activity in response to extracellular signals by mobilizing Notch1 from endosomal stores.
引用
收藏
页码:389 / 395
页数:7
相关论文
共 50 条
  • [1] Glycogen synthase kinase inhibition associated with Notch-1 reduction in cholangiocarcinoma
    Sokolowski, Kevin M.
    Kunnimalaiyaan, Selvi
    Gamblin, T. Clark
    Kunnimalaiyaan, Muthusamy
    CANCER RESEARCH, 2015, 75
  • [2] Glycogen synthase kinase 3 inhibition enhances mineral nodule formation by cementoblasts in vitro
    Abdalla, Henrique
    Storino, Rafael
    Bandeira, Amanda
    Teixeira, Lucas
    Millas, Ana
    Lisboa-Filho, Paulo
    Kantovitz, Kamila
    Nociti Junior, Francisco
    BRAZILIAN ORAL RESEARCH, 2023, 37
  • [3] Glycogen synthase kinase-3 inhibitor AR-A014418 suppresses pancreatic cancer cell growth via inhibition of GSK-3-mediated Notch1 expression
    Kunnimalaiyaan, Selvi
    Gamblin, T. Clark
    Kunnimalaiyaan, Muthusamy
    HPB, 2015, 17 (09) : 770 - 776
  • [4] Inhibition of glycogen synthase kinase-3β enhances cognitive recovery after stroke: the role of TAK1
    Venna, Venugopal Reddy
    Benashski, Sharon E.
    Chauhan, Anjali
    McCullough, Louise D.
    LEARNING & MEMORY, 2015, 22 (07) : 336 - 343
  • [5] Glycogen synthase kinase-3β modulates notch signaling and stability
    Foltz, DR
    Santiago, MC
    Berechid, BE
    Nye, JS
    CURRENT BIOLOGY, 2002, 12 (12) : 1006 - 1011
  • [6] INHIBITION OF GLYCOGEN-SYNTHASE KINASE-3 BY POLYCATIONS
    HEGAZY, MG
    SCHLENDER, KK
    WILSON, SE
    REIMANN, EM
    FASEB JOURNAL, 1988, 2 (04): : A596 - A596
  • [7] QSAR modeling of the inhibition of Glycogen Synthase Kinase-3
    Katritzky, Alan R.
    Pacureanu, Liliana M.
    Dobchev, Dimitar A.
    Fara, Dan C.
    Duchowicz, Pablo R.
    Karelson, Mati
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (14) : 4987 - 5002
  • [8] Glycogen synthase kinase 3 activity enhances liver in flammation in MASH
    Khoury, Mireille
    Guo, Qianqian
    Furuta, Kunimaro
    Correia, Cristina
    Meroueh, Chady
    Lee, Hyun Se Kim
    Warasnhe, Khaled
    Valenzuela-Perez, Lucia
    Mazar, Andrew P.
    Kim, Iljung
    Noh, Yung-Kyun
    Holmes, Heather
    Romero, Michael F.
    Sussman, Caroline R.
    Pavelko, Kevin D.
    Islam, Shahidul
    Bamidele, Adebowale O.
    Hirsova, Petra
    Ibrahim, Samar H.
    JHEP REPORTS, 2024, 6 (06)
  • [9] Glycogen Synthase Kinase Inhibition Enhances Human Monocyte Activity and Augments Atherosclerosis in Mice
    Basu, Nivedita
    Nandy, Debashis
    Mukhopadhyay, Debabrata
    Rajamannan, Nalini M.
    Basu, Ananda
    DIABETES, 2009, 58 : A203 - A203
  • [10] Nuclear glycogen and glycogen synthase kinase 3
    Ragano-Caracciolo, M
    Berlin, WK
    Miller, MW
    Hanover, JA
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 249 (02) : 422 - 427